Top Markets
#1 Wiki Cat Wiki Cat +55.96%
#2 Siren Siren +35.51%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.62%
#4 Ribbita by Virtuals Ribbita by Virtuals +23.21%
#5 PulseChain PulseChain +18.13%
#6 KUB Coin KUB Coin +17.54%
#7 Velvet Velvet +17.48%
#8 OpenEden OpenEden +16.69%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.55%
#10 The Grays Currency The Grays Currency +16.32%
Coin of the day
Wiki Cat Wiki Cat
設定
言語
日本
通貨
USD
テーマ
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
株式のランク #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
株価
$0.01084256
時価総額
$13.87M
変化（1日）
0.00%
変化（1年）
1.70%
国
NZ
取引 BLIS Technologies Limited (BLT)

カテゴリー

Healthcare
BLIS Technologies Limited（BLT）の収益
Aug 2026 時点の収益 TTM: 0
BLIS Technologies Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BLIS Technologies Limited の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE